Life Technologies Corp. v. Promega Corp. (2016)
- Docket
- 14-1538
- Decided
- 2016-01-01
- Public Good score
- 74 / 100
- Framers' Intent score
- 76 / 100
Summary
Question: Does supplying a single component of a multi-component invention from the United States for sale abroad expose the manufacturer to liability for infringement based on worldwide sales? Conclusion: A single component cannot justify liability for the producer of the component.Justice Sonia Sotomayor delivered the opinion for the 7-0 majority. The Court held that, because the phrase “substantial portion” was attached to the phrase “of components of a patented invention” in the text of the statute, the word “substantial” was meant to be read as a quantitative measure. Further, the plural use of the word “components” indicated that a “substantial portion” must always be more than one component. Thus, a single component could never constitute a “substantial portion” of a multi-component invention. The Court also determined that Congress intended this reading because the statute was meant to fill a gap in patent law that prevented enforcement of patent rights on collections of components produced in the United States and sent overseas. Therefore, Lifetech was not liable because it only produced one of the five components required for the kits. In his opinion concurring in part and concurring in the judgment, Justice Samuel A. Alito, Jr., noted that the majority opinion failed to identify what number of components constituted a “substantial portion.” Rather, the opinion only identified that one component is not sufficient. Chief Justice John G. Roberts, Jr., did not participate in the decision of this case.
Case Brief
Facts
Promega Corp. held a patent for a multi-component DNA testing kit. Life Technologies sold a single component (a DNA polymerase enzyme) from the U.S. to foreign purchasers for use in assembling the full kit abroad. Promega sued Life Technologies for patent infringement under 35 U.S.C. § 271(f), alleging that supplying a single component constituted infringement.
Procedural History
Promega sued Life Technologies in the U.S. District Court for the Central District of California. The Ninth Circuit affirmed a district court ruling dismissing the claim. Life Technologies petitioned for certiorari, which the Supreme Court granted.
Issue
Does supplying a single component of a multi-component invention from the United States for assembly abroad constitute patent infringement under 35 U.S.C. § 271(f)(1), which requires supplying a 'substantial portion' of the components?
Holding
No. The supply of a single component does not constitute a 'substantial portion' of the components of a patented invention for purposes of § 271(f)(1) liability.
Rule
The phrase 'substantial portion' in 35 U.S.C. § 271(f)(1) requires a quantitative measurement indicating that the supplied components must exceed one item. The plural term 'components' in the statute and the phrase 'substantial portion' together mandate that a 'substantial portion' must consist of more than a single component.
Reasoning
The Court interpreted the plain text of § 271(f)(1), noting that 'substantial portion' modifies the plural 'components' and thus requires more than one component. The statutory context revealed Congress intended to permit U.S. patent holders to recover for supplying components intended for foreign assembly when multiple components are supplied. The Court rejected the argument that a single component could ever satisfy the statutory threshold given the language's clear quantitative and plural requirements.
Significance
The decision limits the extraterritorial reach of U.S. patent law by requiring multiple components to be supplied for infringement liability under § 271(f), promoting clarity in international patent enforcement and reducing the risk of unintended patent claims against manufacturers engaged in global supply chains.
Public Good Analysis
GPT: The decision prevents overly broad patent enforcement that could stifle international innovation and competition, supporting economic fairness by clarifying that single components do not trigger liability. This promotes a predictable legal environment for businesses, encouraging investment in research and development that benefits consumers through new products and services. | Claude: This decision clarifies patent law regarding components sold internationally, fostering innovation by preventing overly broad interpretations of infringement. It protects American companies from potentially crippling liability based on the export of common parts used in foreign-made products, promoting economic fairness and international trade. The ruling’s focus on statutory text also provides needed clarity for businesses.
Framers' Intent Analysis
GPT: The Court's textualist interpretation aligns with the Founders' emphasis on limited government and clear statutory language, as reflected in the Patent Clause (Art. I, § 8, cl. 8) that requires Congress to define patent scope precisely. This approach avoids judicial overreach into legislative authority, respecting the framers' principle that law must be written in plain terms to protect liberty from arbitrary enforcement. | Claude: The framers intended a patent system to *promote* innovation, but also understood the need for clear boundaries on property rights; Federalist 43 highlights the importance of defining intellectual property protections. While not directly addressing component-level exports, the emphasis on textualism – interpreting the statutory language as written – aligns with originalist principles espoused by figures like Alexander Hamilton who favored a robust yet defined protection of inventions to stimulate economic growth and avoid arbitrary expansions of power.